K Number
K182313
Date Cleared
2019-03-11

(196 days)

Product Code
Regulation Number
872.3640
Panel
Dental
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

BoneTrust® Dental Implants are medical devices intended to be surgically placed in the bone of the maxillary and/or mandibular arches to provide support for prosthetic restorations (crowns, bridges or overdenture) in edentulous or partially edentulous patients to restore a patients' chewing function.

BoneTrust® implants can also be used for immediate loading when sufficient primary stability is achieved and with appropriate occlusal loading.

BoneTrust® Short Dental Implants with length 6.5 mm are intended for delayed loading only

BoneTrust® Abutments and Prosthetic parts are intended for use with Bone Trust Dental Implants in the maxillary and/or mandibular arches to provide support for crowns, bridges or overdentulous or partially edentulous patients.

Device Description

The BoneTrust® Implant System includes various sizes of threaded root-form dental implants and abutments intended to support prosthetic restorations in edentulous or partially edentulous patients.

The BoneTrust® Implants are bone level, root form implants constructed of commercially pure titanium (Grade 4) per ISO 5832-2, with a sand-blasted, acid-etched surface treatment. BoneTrust® Implants are screw- shaped dental implants with a Hexagon or conical torx internal connection.

BoneTrust® Dental Abutments are intended for cement-retained and screw-retained restorations. A cylindrical internal hexagon or conical torx allows connection to the BoneTrust® implant. BoneTrust® Dental Abutments are available in different designs

AI/ML Overview

This document is a 510(k) summary for the BoneTrust® Implant System. It focuses on demonstrating substantial equivalence to predicate devices rather than proving a device meets specific acceptance criteria through a standalone study for novel performance metrics. Therefore, many of the requested sections about acceptance criteria, sample sizes, ground truth establishment, expert adjudication, and MRMC studies are not applicable.

However, I can extract the information provided regarding non-clinical testing used to support substantial equivalence.

Here's a breakdown of the requested information based on the provided text:

1. A table of acceptance criteria and the reported device performance

The document does not explicitly state quantitative acceptance criteria in terms of performance metrics (e.g., accuracy, sensitivity, specificity) for a novel AI device. Instead, it relies on demonstrating "substantial equivalence" through non-clinical testing to legally marketed predicate devices. The "reported device performance" is essentially that the device performed comparably to predicate devices in the described tests.

Acceptance Criterion (Implicit)Reported Device Performance
Biocompatibility in accordance with ISO 10993 seriesTests (including cytotoxicity per ISO 10993-5) support substantial equivalence to legally marketed predicate devices.
Fatigue strength of the implant-abutment interfaceTested for representative samples in accordance with ISO 14801. Results support substantial equivalence to legally marketed predicate devices.
Sterilization validation (for non-sterile devices)Validation conducted per ISO 17665-1 and ISO 17665-2 for pre-vacuum steam sterilization (wrapped cycle), demonstrating a sterility assurance level (SAL) of 10^-6.
Sterilization validation (for sterile devices)Validation conducted per ISO 11137-1 and 11137-2 for Beta-radiation sterilization. Shelf life testing per ISO 11607-1 and ASTM F1980 (accelerated and real-time aging). LAL testing per USP 85 and FDA Guidance.
Implant Surface AnalysisInvestigation using EDX, SEM, and BSE. Results support substantial equivalence to legally marketed predicate devices.
Performance of BoneTrust® Short ImplantsComparative surface area analysis, comparative bone-to-implant contact study (using animal histology), and comparative pull-out strength test. Results support substantial equivalence to legally marketed predicate devices.

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

The document does not provide specific sample sizes for the test sets in the non-clinical studies. It mentions "representative samples" for fatigue testing. Data provenance is not specified beyond being non-clinical testing performed to support substantial equivalence to legally marketed predicate devices.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not applicable. This is a 510(k) submission for a physical medical device (dental implants and abutments), not an AI/software device requiring ground truth establishment by human experts for diagnostic or similar tasks. The "ground truth" for the non-clinical tests would be the measurement results from the tests themselves (e.g., cytotoxicity levels, fatigue limits, physical characteristics).

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable, as this is for a physical device and involves objective non-clinical tests rather than subjective human interpretation needing adjudication.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This is not an AI-assisted diagnostic or interpretation device.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable. This is a physical device, not an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

For the non-clinical studies performed, the "ground truth" would be objective measurements obtained through standardized testing methods, such as:

  • Biocompatibility: Laboratory results (e.g., cell viability in cytotoxicity tests).
  • Fatigue testing: Load cycles to failure or endurance limit under specified conditions, as per ISO 14801.
  • Sterilization: Sterility Assurance Level (SAL), microbial ingress testing, package integrity.
  • Implant Surface Analysis: Microscopic imagery (SEM, BSE) and elemental composition data (EDX).
  • Short Implants Performance: Quantitative measurements from comparative surface area analysis, histological examination for bone-to-implant contact (animal study), and force measurements for pull-out strength tests.

8. The sample size for the training set

Not applicable. There is no training set mentioned for this physical device.

9. How the ground truth for the training set was established

Not applicable. There is no training set for this physical device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" followed by the words "U.S. FOOD & DRUG ADMINISTRATION".

March 11, 2019

Medical Instinct Deutschland GmbH % Andre Weingerl RA Consultant WRC Consulting Am Hohsetter 1A Steislingen 78256 GERMANY

Re: K182313

Trade/Device Name: BoneTrust® Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: February 6, 2019 Received: February 13, 2019

Dear Andre Weingerl:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Andrew I. Steen -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K182313

Device Name BoneTrust® Implant System

Indications for Use (Describe)

BoneTrust® Dental Implants are medical devices intended to be surgically placed in the bone of the maxillary and/or mandibular arches to provide support for prosthetic restorations (crowns, bridges or overdenture) in edentulous or partially edentulous patients to restore a patients' chewing function.

BoneTrust® implants can also be used for immediate loading when sufficient primary stability is achieved and with appropriate occlusal loading.

BoneTrust® Short Dental Implants with length 6.5 mm are intended for delayed loading only

BoneTrust® Abutments and Prosthetic parts are intended for use with Bone Trust Dental Implants in the maxillary and/or mandibular arches to provide support for crowns, bridges or overdentulous or partially edentulous patients.

Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

medical i

K182313

510(k) Summary

Date Prepared: 2019-03-09

APPLICANT: Medical Instinct Deutschland GmbH Graseweg 24 37120 Bovenden Germany Tel.: +49 5593 95196 Fax.: +49 5593 95195

E-Mail: info@medical-instinct.de Internet: www.medical-instinct.de

CONTACT PERSON: Jan Worlitz Managing Director Tel.: +49 5593 95196 E-Mail: worlitz@medical-instinct.de

{4}------------------------------------------------

medica

Device Name 1.

Trade Names:BoneTrust® Implant System
Classification Name:Endosseous dental implant

2. Classification Product Code / Subsequent Code

BoneTrust® Implant System can be classified according to following Device Name and Product Code:

Product Code:DZE
Device Class:2
Classification Panel:Dental
Regulation number:21 CFR 872.3640
Secondary Product Code:NHA

3. Predicate device

. Primary Predicate Device

Straumann Dental Implant System; Stramann USA, LLC

#K150938

Reference Devices .

CAMLOG Abutments; Altatec GmbH#K083496
Nobelactive Multi Unit Abutments; Nobel Biocare AB#K072570
Straumann RN synOcta UCLA Gold Abutment; Institut Straumann AG#K041295
Conelog Implant System; Altatec GmbH#K113779
STRAUMANN HEALING ABUTMENTS, HEALING CAPS, CLOSURE SCREWS#K130808
SIC Invent Dental Implant Systems; SIC Invent AG#K173207
BIOMET 3i Dental Abutments#K072642
XIVE@ Dental Implant System#K021318
Healing Cap Multi-Unit Titanium, Nobel Biocare AB#K171142

{5}------------------------------------------------

Device Description 4.

The BoneTrust® Implant System includes various sizes of threaded root-form dental implants and abutments intended to support prosthetic restorations in edentulous or partially edentulous patients.

Implants 4.1.

The BoneTrust® Implants are bone level, root form implants constructed of commercially pure titanium (Grade 4) per ISO 5832-2, with a sand-blasted, acid-etched surface treatment. BoneTrust® Implants are screw- shaped dental implants with a Hexagon or conical torx internal connection.

Bone Trust Implants are provided in the following specifications:

Representative PictureSpecificationValue
Image: Dental ImplantSizes - Diameter x length(mm)3.4 x 8.0 / 3.4 x 10.0 / 3.4 x 11.5 / 3.4 x 13.0 / 3.4 x 14.54.0 x 6.5 / 4.0 x 8.0 / 4.0 x 10.0 / 4.0 x 11.5 / 4.0 x 13.0 /4.0 x 14.55.0 x 6.5 / 5.0 x 8.0 / 5.0 x 10.0 / 5.0 x 11.5 / 5.0 x 13.0
DesignConical screw implantSelf-tapping screw designIntegrated "platform switching"Internal connection hexagonal / internal connection with conical torx socket
MaterialTitan Grade 4 (ISO 5832-2:1999 / ASTM F67-06:2006)
SurfaceMicro-structured blasted etched surface passivated
Packaging / SterilizationSterile packed in blister; Sterilized by beta irradiation

4.2. Abutments

BoneTrust® Dental Abutments are intended for cement-retained and screw-retained restorations. A cylindrical internal hexagon or conical torx allows connection to the BoneTrust® implant. BoneTrust® Dental Abutments are available in different designs

4.2.1. Esthetic Abutments

BoneTrust® Esthetic and Wide Body Abutments are premanufactured single-piece abutments constructed of titanium alloy per ISO 5832-3 and intended to be used for cemented single-tooth and bridge restorations as well as temporary single tooth restorations. BoneTrust® Esthetic Abutments are available in the following shapes:

Esthetic Abutments
Available sizesPlatform DiameterSizes (Angulation, Gingival Height (GH))
Ø3.40°: GH 0.5, 2.5, 4.5mm15°: GH 0.5, 2.5mm20°: GH 0.7mm
Ø4.00°: GH 0.5, 2.5, 4.5mm15°: GH 0.5, 2.5mm
Ø5.00°: GH 2.5mm15°: GH 0.5mm, 2.5mm
Total Abutment Height [mm]10.1 to 11.6
DesignHexagonal connection / conical torx socket connection
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized

{6}------------------------------------------------

Esthetic Abutments
Packaging / Sterilization
Packed in an individual PE bag - Must be sterilized by the user.
End User ModificationWall thickness/diameter
Post height
Angulation and divergence
Gingival height
No modifications allowed
Connection platform
No modifications allowed
Method of modification
Hand Tools only

Wide Body Abutments 4.2.2.

BoneTrust® Wide Body Abutments are premanufactured single-piece abutments constructed of titanium alloy per ISO 5832-3 and intended to be used for cemented single-tooth and bridge restorations as well as temporary single tooth restorations.

Wide Body Abutment and Wide Body Abutment cone+ feature bigger body diameter compared to the Esthetic Abutment / Esthetic Abutment cone+ which allows the option of switching to a wider prosthetic platform

The abutment might be shortened up to a minimum abutment post height of 5 mm. the abutments are not intended for angular correction, correction of diameter or taper

Wide Body Abutments
Image: dental abutmentAngulation (°)0
Available SizesPlatform DiameterGingival Height (GH)
3.4 mm / 4.0 mm3.0 mm
5.0 mm3.0 mm
Total Abutment Height [mm]11.2 to 12.2
DesignHexagonal connection / conical torx socket connection
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized
Packaging / SterilizationPacked in an individual PE bag - Must be sterilized by the user.
End User ModificationWall thickness/diameter
Post height
Angulation and divergence
Gingival height
Connection platform
Method of modification

{7}------------------------------------------------

4.2.3. UCLA Abutments

BoneTrust® UCLA Abutments are intended to be used as a pattern for the creation of customized veneered crowns for cemented or screw retained single-tooth and bridge restorations. BoneTrust® UCLA Abutments are available in the following shapes:

UCLA Abutments
Image: [abutments]Angulation [°]0
Platform Diameter [mm]3.4 / 4.0 / 5.0
Body Diameter [mm]2.8
Cylinder Height [mm]3.0
DesignHexagonal connection with / without rotation stop
DesignConical torx socket connection with / without rotation stop
Material for Precious AlloysHeraplat Au 61%, Pt 23.8 %, Pd 15 %, Rh 0.2 %
Material for Non Precious AlloysPtIr20% (ISO 22674)
SurfaceAnodized
Packaging / SterilizationPacked in an individual PE bag - Must be sterilized by the user.
End User ModificationNo modification allowed to the abutmentBurn-out plastic sleeve may be shortened down to a minimum height of 4 mm

4.2.4. Direct Abutment

BoneTrust® Direct Abutments are premanufactured multi-unit abutments constructed of titanium alloy per ISO 5832-3 and intended to be used for splinted and occlusally screwed prosthetics, such as bridges, hybrid prostheses and cast bars,. BoneTrust® Direct Abutments are two piece abutments intended for use in combination with Auro Base Direct Abutments. BoneTrust® Direct Abutments are available in the following shapes:

Direct Abutments
Available SizesAngulationSize (diameter in mm x Gingival Height in mm)
3.4/4.0 x GH 1.03.4/4.0 x GH 3.0
20°3.4/4.0 x GH 2.0
30°3.4/4.0 x GH 2.0
Total Abutment Height [mm]9.1 to 12.2
DesignHexagonal connection / conical torx socket connection
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized
Compatible AbutmentsBonteTrust® Direct Healing AbutmentsBoneTrust® AuroBase Abutments
Packaging / Sterilizationpacked in an individual PE bag - Must be sterilized by the user.
End User ModificationNo modification allowed

{8}------------------------------------------------

4.2.5. AuroBase Direct Abutments

BoneTrust® AuroBase Direct Abutments are premanufactured multi-unit abutments intended to be used as a pattern for the creation of customized veneered crowns for splinted and occlusally screwed prosthetics, such as bridges, hybrid prostheses and cast bars. BoneTrust® AuroBase Direct Abutments are two piece abutments intended for use in combination with Direct Abutments.

Auro Base Abutment
Angulation (°)0
Cylinder Height (mm)3.2
Platform diameter D (mm)3.4 / 4.0
Body diameter (mm)3.15
DesignHexagonal connection / conical torx socket connection
Material for Precious AlloysHeraplat Au 61%, Pt 23.8 %, Pd 15 %, Rh 0.2 %
Material for Non Precious AlloysPtlr20% (ISO 22674)
SurfaceAnodized
Compatible AbutmentsBonteTrust® Direct Abutments
Packaging / Sterilizationpacked in an individual PE bag - Must be sterilized by the user.
End User ModificationNo modification allowed to the abutmentBurn-out plastic sleeve may be shortened down to a minimum height of 4 mm

4.2.6. Telescopic Abutment

BoneTrust® Telescopic Abutments are constructed of titanium alloy per ISO 5832-3 and intended to be used for fixation of friction retained removable restorations and bridges. BoneTrust® telescopic Abutments are available with hexagon or conical torx connection with 3.4 / 4 mm Platform.

Telescopic Abutment
Angulation (°)0
Platform diameter D (mm)3.4 / 4
Body diameter (mm)5
Total Abutment Height [mm]8.0 to 10.8
DesignHexagonal connection / conical torx socket connection
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized
Packaging / Sterilizationpacked in an individual PE bag - Must be sterilized by the user.
End User ModificationWall thickness/diameterNo modifications allowed
Post heightNo modifications allowed
Angulation and divergenceMaximum Taper of 5° to correct diver-gence between implants
Gingival heightNo modifications allowed
Connection platformNo modifications allowed
Method of modificationHand Tools only

{9}------------------------------------------------

Healing Abutment 4.2.7.

BoneTrust® Healing Abutments are premanufactured abutments constructed of titanium alloy per ISO 5832-3 and intended to be used temporarily during the healing period of the BoneTrust® implant to prepare gingival tissue for acceptance of the final abutment. BoneTrust® Healing Abutments are available in the following shapes:

Image: dental abutmentsHealing Abutment
Angulation (°)0
Available SizesPlatform DiameterGingival Height (GH)
3.4 mm1.5 mm, 3.0 mm, 5.0 mm, 7.0 mm
4.0 mm1.5 mm, 3.0 mm, 5.0 mm
5.0 mm1.5 mm, 3.0 mm, 5.0 mm
Total Abutment Height [mm]6.5 to 12.6
DesignHexagonal connection / conical torx socket connection
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized
Packaging / Sterilizationpacked in an individual PE bag - Must be sterilized by the user.
Maximum intraoral Use180 Days
LoadNon-occlusal load

Direct Healing Abutment 4.2.8.

BoneTrust® Direct Healing Abutments are premanufactured abutments designed to be mounted on BoneTrust® Direct Abutments. They are constructed of titanium alloy per ISO 5832-3 and indicated for use with the BoneTrust® Direct Abutments during the healing period of the BoneTrust® implant to prepare gingival tissue for acceptance of the final abutment. They are intended for use of up to 180 days during endosseous and gingival healing and are for non-occlusal restorations. BoneTrust® Direct Healing Abutments are available in the following shapes:

Direct Healing Abutment
Image: Direct Healing AbutmentAngulation [°]0
Diameter [mm]4.9
Length [mm]4.75
MaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
SurfaceAnodized
Packaging / SterilizationPacked in an individual PE bag - Must be sterilized by the user.
Maximum Intraoral Use180 Days
LoadNon-occlusal load

{10}------------------------------------------------

4.2.9. Healing Abutments Wide Body

BoneTrust® Wide Body Healing Abutments are premanufactured abutments constructed of titanium alloy per ISO 5832-3 and indicated for use with the BoneTrust® Implant System during the healing period of the BoneTrust® implant to prepare gingival tissue for acceptance of the final abutment. They are intended for use of up to 180 days during endosseous and gingival healing and are for non-occlusal loading of provisional restorations. BoneTrust® Healing Abutments Wide Body are available in the following shapes:

Healing Abutment - Wide Body
Image: dental abutmentsAngulation (°)0
Image: dental abutmentsAvailable SizesPlatform DiameterGingival Height (GH)
3.4 mm / 4.0 mm3.0 mm, 5.0 mm
5.0 mm3.0 mm, 5.0 mm
Image: dental abutmentsTotal Abutment Height [mm]8.6 to 10.6
Image: dental abutmentsDesignHexagonal connection / conical torx socket connection
Image: dental abutmentsMaterialTitan Grade 5 (ISO 5832-3 / ASTM F136)
Image: dental abutmentsSurfaceAnodized
Image: dental abutmentsPackaging / Sterilizationpacked in an individual PE bag - Must be sterilized by the user.
Image: dental abutmentsMaximum intraoral Use180 Days
Image: dental abutmentsLoadNon-occlusal load

5. Indications for Use

BoneTrust® Dental Implants are medical devices intended to be surgically placed in the bone of the maxillary and/or mandibular arches to provide support for prosthetic restorations (crowns, bridges or overdenture) in edentulous or partially edentulous patients to restore a patients' chewing function.

Bone Trust® implants can also be used for immediate loading when sufficient primary stability is achieved and with appropriate occlusal loading.

BoneTrust® Short Dental Implants with length 6.5 mm are intended for delayed loading only

BoneTrust® Abutments and Prosthetic parts are intended for use with Bone Trust Dental Implants in the maxillary and/or mandibular arches to provide support for crowns, bridges or overdenture for edentulous or partially edentulous patients.

{11}------------------------------------------------

Technological Characteristics and Substantial Equivalence 6.

6.1. Comparison of Indications for Use

The indications for use of the subject devices are compared to the primary predicate and reference devices in the following tables:

Candidate:Primary Predicate:Discussion
CompanyMedical Instinct DeutschlandGmbHStraumann AG
DeviceNameBoneTrust® Implant SystemDental Implant System - Roxolid®SLA Implants--
510(K)number--K150938--
Indica-tions forUseBoneTrust® Dental Implants aremedical devices intended to besurgically placed in the bone of themaxillary and/or mandibular archesto provide support for prostheticrestorations (crowns, bridges oroverdenture) in edentulous orpartially edentulous patients torestore a patients' chewing function.Straumann® dental implants areindicated for oral endosteal implanta-tion in the upper and lower jaw and forthe functional and esthetic oral rehabil-itation of edentulous and partiallydentate patients. Straumann dentalimplants can also be used for immedi-ate or early implantation followingextraction or loss of natural teeth.Implants can be placed with immediatefunction on single-tooth and/or multipletooth applications when good primarystability is achieved and with appropri-ate occlusal loading, to restore chew-ing function. The prosthetic restora-tions used are single crowns, bridgesand partial or full dentures, which areconnected to the implants by thecorresponding elements (abutments).Both implant-systems are indicatedfor placement in the patient's jaw toprovide support for prosthetic resto-rations in edentulous or partiallyedentulous patientsThe wording "maxillary and/or man-dibular arches" has the same mean-ing as "upper and lower jaw."Further minor differences in lan-guage do not impact the safety andeffectiveness of the subject device.
Bone Trust® implants can also beused for immediate loading whensufficient primary stability isachieved and with appropriateocclusal loading.Booth Implant Systems may be usedfor immediate loading when goodprimary stability is achieved.Minor differences in language do notimpact the safety and effectivenessof the subject device.
BoneTrust® Short Dental Implantswith length 6.5 mm are intended fordelayed loading onlyThe inclusion of 6.5mm length spe-cific language does not impact thesafety and effectiveness of thesubject device.
BoneTrust® Abutments andProsthetic parts are intended foruse with Bone Trust DentalImplants in the maxillary and/ormandibular arches to providesupport for crowns, bridges oroverdenture for edentulous orpartially edentulous patients.Similar to primary predicate Indica-tions for UseThe wording "maxillary and/or man-dibular arches" has the same mean-ing as "upper and lower jaw."Further minor differences in lan-guage do not impact the safety andeffectiveness of the subject device.Further reference devices used fortechnological comparisons ofBoneTrust® Abutments do notinclude any component-specificlanguage that would raise any con-cern related to the safety and effec-tiveness of the subject devices.Further minor differences in lan-
guage do not impact the safety andeffectiveness of the subject device

{12}------------------------------------------------

Comparison of Technological Characteristics 6.2.

The technological characteristics of the subject devices are compared to the primary predicate and reference devices in the following tables:

6.2.1. BoneTrust® plus/cone+ implant

CompanyCandidate:Medical InstinctDeutschland GmbHPrimary Predicate:Straumann AGReference Device:SIC Invent AGDiscussion
DeviceNameBoneTrust plus/cone+implantDental Implant System -Roxolid® SLA ImplantsSIC Ace / Max Implants--
510(K)number--K150938K173207--
ImplantmaterialTitan Grade 4 ASTM F67Titanium Grade 4Titanium Grade 4Identical
ImplantTypeScrew-typeScrew-typeScrew-typeIdentical
DesignConicalConicalConicalIdentical
LoadDelayed and ImmediateDelayed and ImmediateDelayed and ImmediateIdentical
Unitrestora-tionPartial or total tooth lossPartial or total tooth lossPartial or total tooth lossIdentical
Single ortwo pieceTwo piecesTwo piecesTwo piecesIdentical
ScrewtypeSelf-threadingSelf-threadingSelf-threadingIdentical
Distal endWith threadWith threadWith threadIdentical
Implant toabutmentconnec-tionCylindrical Internal Hexa-gon or conical torxNarrow Neck CrossFit®(NNC)Regular Neck (RN)Wide Neck (WN)Hex 2.3Morse TaperResults of fatiguetesting support thatdifferences do notraise any concernsin regard to safetyand effectiveness ofthe implant abutmentinterface.

{13}------------------------------------------------

CompanyCandidate:Medical InstinctDeutschland GmbHPrimary Predicate:Straumann AGReference Device:SIC Invent AGDiscussion
ImplantDimen-sions(DiameterX Length)Ø3.4 X 8Ø3.4 X 10Ø3.4 X 11,5Ø3.4 X 13Ø3.4 X14,5Ø4 X 6.5Ø4 X 8Ø4 X 10Ø4 X 11.5Ø4 X 13Ø4 X 14.5Ø5 X 6.5Ø5 X 8Ø5 X 10Ø5 X 11.5Ø5 X 13Ø3.3 X 8Ø3.3 X 10Ø3.3 X 12Ø3.3 X 14Ø4.1 X 6Ø4.1 X 8Ø4.1 X 10Ø4.1 X 12Ø4.1 X 14Ø4.8 X 6Ø4.8 X 8Ø4.8 X 10Ø4.8 X 12Ø4.8 X 14Ø3.4 / 3.7 X 7.5Ø3.4 / 3.7 X 9.5Ø3.4 / 3.7 X 11,5Ø3.4 / 3.7 X 13Ø3.4 / 3.7 X14,5Ø4.0 / 4.2 X 6.0Ø4.0 / 4.2 X 7.5Ø4.0 / 4.2 X 9.5Ø4.0 / 4.2 X 11.5Ø4.0 / 4.2 X 13.0Ø4.0 / 4.2 X 14.5Ø4.5 / 4.7 X 6.0Ø4.5 / 4.7 X 7.5Ø4.5 / 4.7 X 9.5Ø4.5 / 4.7 X 11.5Ø4.5 / 4.7 X 13.0Ø4.5 / 4.7 X 14.5Ø5.0 / 5.2 / 4.7 X 6.0Ø5.0 / 5.2 / 4.7 X 7.5Ø5.0 / 5.2 / 4.7 X 9.5Ø5.0 / 5.2 / 4.7 X 11.5Ø5.0 / 5.2 / 4.7 X 13Ø5.0 / 5.2 / 4.7 X 14.5Reference devicehas been used toaddress any dimen-sions not cleared inthe primary predi-cate submission.
Surfacetreatmentblasted-etchedSLA grit blast andacid etch surfaceblasted-etchedResults of non-clinical testing sup-port that differencesin surface character-istics do not raiseany concerns inregard to safety andeffectiveness of theproposed devices

{14}------------------------------------------------

6.2.2. Esthetic Abutments

CompanyCandidate:Reference Device:Discussion
Medical Instinct Deutschland GmbHAltatech GmbH
Device NameBoneTrust® Esthetic AbutmentsCAMLOG Abutments--
510(K) num-ber--K083496--
MaterialTitanium alloy TiAl4VTitanium alloy TiAl4VIdentical
SurfaceAnodized surfaceAnodized surfaceIdentical
SizeØ3.4:0°: GH 0.5, 2.5, 4.5mm15°: GH 0.5, 2.5mm20°: GH 0.7mmØ4.0:0°: GH 0.5, 2.5, 4.5mm15°: GH 0.5, 2.5mmØ5.0:0°: GH 2.5mm15°: GH 0.5mm, 2.5mmTotal Abutment height: 10.1 mm, 11.6 mmPlatform Diameter: ø 3.3 - 3.8 - 4.3 - 5.0 -6.0 mmBody Diameter: 4.5 to 8.0 mmGingival Height: 0.8 - 1.0 - 1.8 - 2.5 - 3.0 -4.5 mmTotal Abutment height: 8.7 mm - 11.7 mmSubstantially equiva-lentSizes are withinrange of the Refer-ence Device, exceptGingival Height (GH)of 0.5 / 0.7mm. Thisdifference does notraise any concernsin regard to safetyand effectiveness ofthe proposed devic-es
ConnectionCylindrical external Hexagon or andconical torxConical fittingResults of dynamicfatigue testing sup-port that differencesin inner geometry donot raise any con-cerns in regard tosafety and effective-ness of the implantabutment interface.
Angulation0° - 15° - 20°0° - 15° - 20°Identical

6.2.3. Wide Body Abutments

CompanyCandidate:Reference Device:Discussion
Medical Instinct Deutschland GmbHAltatech GmbH
Device NameBoneTrust® Wide Body AbutmentsCAMLOG Abutments--
510(K) num-ber--K083496--
MaterialTitanium alloy TiAl4VTitanium alloy TiAl4VIdentical
SurfaceAnodized surfaceAnodized surfaceIdentical
SizePlatform Diameter: ø 3.4 - 4.0 - 5.0 mmBody Diameter: 7.4 / 7.6 mmGingival Height: 3.0 mmTotal Abutment height: 11.2 mm, 11.6 mmPlatform Diameter: ø 3.3 - 3.8 - 4.3 - 5.0 -6.0 mmBody Diameter: 4.5 to 8.0 mmGingival Height: 0.8 - 1.0 - 1.8 - 2.5 - 3.0 -4.5 mmTotal Abutment height: 8.7 mm - 11.7 mmSizes are withinrange of ReferenceDevice,

{15}------------------------------------------------

ConnectionCylindrical external Hexagon or and coni-cal torxConical fittingResults of dynamicfatigue testing sup-port that differencesin inner geometry donot raise any con-cerns in regard tosafety and effective-ness of the implantabutment interface
Angulation$0^{\circ}$$0^{\circ}$ - 15° - 20°within range ofReference device

6.2.4. UCLA Abutments

CompanyCandidate:Medical Instinct Deutsch-land GmbHReference Device:Institut Straumann AGReference DeviceBiomet 3iDiscussion
DeviceNameBoneTrust® AbutmentsRN synOcta UCLA GoldAbutmentUCLA Gold / castableAbutment--
510(K)number--K041295K072642--
MaterialHeraplat Au 61%, Pt 23,8%,Pd, 15% Rh 0,2% /Platinum-Iridium-alloy(Ptlr20%)Ceramicor®Au 60%, Pd 20%, Pt 19%,Ir 1%Machined Gold AlloyMaterials conform to ISO22674 standard. Bio-compatibility Assess-ment and testing supportsubstantial equivalenceto reference device
MaterialBurn out-sleevePOMPOMPlasticIdentical to K041295
SizeDiameter ø 3.4, 4.0, 5.0 mmCylinder height: 3 mmDiameter: 4.8, 6.5Cylinder height: 1.8 - 3.35mmDiameterø 3.4, 4.1, 5.0, 6.0 mmCylinder height: 4 mmDiameters are within therange of K072642, Cyl-inder Heights and totalheights are similar toK041295
SurfaceAnodizedAnodizedAnodizedIdentical
ConnectionCylindrical external Hexagonor conical torxSynOcta connectionCone -octagonHexed and non-hexedconnectionResults of dynamicfatigue testing supportthat differences in innergeometry do not raiseany concerns in regardto safety and effective-ness of the implantabutment interface

6.2.5. Direct Abutment

CompanyCandidate:Reference Device:Discussion
Medical Instinct Deutschland GmbHNobel Biocare AB
Device NameBoneTrust® AbutmentsNobelActive Multi Unit Abutment – GoldCoping Multi-Unit Abutment--
510(K) num-ber--K072570--
MaterialTitanium alloy TiAl4VCP titanium (Grade 4)Titanium alloy TiAl4VIdentical

{16}------------------------------------------------

SurfaceAnodized surfacemachinedResults of biocompati-bility assessment andtesting support thatdifferences in surfacetreatment do not raiseany concerns in regardto safety and effective-ness of the proposeddevice
SizeDiameter Ø 3.4, 4.0, 5.0 mmGingival Height: 1, 2, 3 mmTotal height: 9.1, 9.4 mmDiameter Ø 3.5, 4.3, 5.0 mmGingival Height: 1, 2, 3, 4, 5 mmTotal height: not knownPlatform Sizes areadapted to platformdiameter of the implantsystem. Minor differ-ences do not raise anyconcerns in regard tosafety and effectivenessof the proposed device
ConnectionCylindrical external Hexagon or and coni-cal torxExternal Hex, ConicalResults of dynamicfatigue testing supportthat differences in innergeometry do not raiseany concerns in regardto safety and effective-ness of the implantabutment interface
Angulation0°, 20°, 30°0°, 17°, 30°Within range of Refer-ence Device

6.2.6. Auro Base Abutment

CompanyCandidate:Reference Device:Discussion
CompanyMedical Instinct Deutschland GmbHNobel Biocare AB
Device NameBoneTrust® AbutmentsNobelActive Multi Unit Abutment - GoldCoping Multi-Unit Abutment--
510(K) num-ber--K072570--
MaterialHeraplat Au 61%, Pt 23,8%, Pd, 15% Rh0,2% /Platinum-Iridium-alloy (PtIr20%)Au 60%, Pd 20%, Pt 19%, Ir 1%Materials conform toISO 22674 standard.Biocompatibility As-sessment and testingsupport substantialequivalence to refer-ence device
Material Burnout sleevePOMBurn out plasticSubstantially equivalent
SurfaceMachinedmachinedIdentical
SizeCylinder Height [mm]: 3.2Platform Diameter [mm]: 3.4 / 4.0Body Diameter [mm]: 3.1Cylinder Height [mm]: 3.0Platform Diameter [mm]: Ø 3.5, 4.3, 5.0mmBody Diameter [mm]: not knownResults of dynamicfatigue testing supportthat differences inAbutment size do notraise any concerns inregard to safety andeffectiveness of theproposed device

{17}------------------------------------------------

ConnectionCylindrical external Hexagon or and coni-cal torxExternal Hex, ConicalResults of dynamicfatigue testing supportthat differences in innergeometry do not raiseany concerns in regardto safety and effective-ness of the implantabutment interface
AngulationIdentical

6.2.7. Telescopic Abutment

CompanyCandidate:Medical Instinct Deutsch-land GmbHReference Device:Altatech GmbHReference DeviceDentsply Implants GmbHDiscussion
DeviceNameBoneTrust® TelescopicAbutmentsCONELOG TelescopicAbutmentsFriadent Telescopic Abut-ment--
510(K)number--K113779K021318--
MaterialTitanium alloy TiAl4VTitanium alloy TiAl4VTitanium alloy TiAl4VIdentical
SurfaceMachined surfaceMachined surfaceMachined surfaceIdentical
ConnectionCylindrical external Hexa-gon or conical torxConical fittingHexagon connectionResults of dynamicfatigue testing supportthat differences ininner geometry do notraise any concerns inregard to safety andeffectiveness of theimplant abutmentinterface
SizeDiameter: 3,4 / 4 mmDiameters: 3.8, 4.3, 5.0,and 6.0 mmDiameters: 3.4, 3.8, 4.5, 5.5mmWithin range ofK021318
MaximumTaperNot knownidentical to K113779

6.2.8. Healing Abutment

CompanyCandidate:Medical Instinct DeutschlandGmbHReference Device:SIC Invent AGDiscussion
DeviceNameBoneTrust® Healing AbutmentsSIC Gingiva Shaper--
510(K)number--K173207--
Maximumintraoral use180 Days180 DaysIdentical
LoadNon-occlusal loadingNon-occlusal loadingIdentical
MaterialTitanium alloy TiAl4VTitanium alloy TiAl4VIdentical
Surfaceanodized surfaceanodized surfaceIdentical
ConnectionCylindrical external Hexagon orconical torxConical or cylindrical fittingResults of dynamic fatigue test-ing support that differences ininner geometry do not raise anyconcerns in regard to safety andeffectiveness of the implant -abutment interface

{18}------------------------------------------------

SizePlatformDiameterGingival Height(GH)PlatformDiameterGingival Height (GH)Reference device does notinclude a device with platformdiameter equal to or smaller than3.4 mm with a gingival height of7.0 mm.The inclusion of a Ø3.4x7.0 mmHealing Abutment does notimpact safety and effectivenessas healing abutments are placedout of occlusion. The gingivalheight is only to shape the gingi-va, not withstand load
3.4 mm1.5 mm, 3.0 mm,5.0 mm, 7.0 mm3.0 mm1.0 mm, 2.0 mm, 3.0mm, 4.0 mm, 5.0 mm,
4.0 mm1.5 mm, 3.0 mm,5.0 mm3.7 mm1.0 mm, 1.5 mm, 2.0mm, 3.0 mm, 4.0 mm,5.0 mm, 7.0 mm
5.0 mm1.5 mm, 3.0 mm,5.0 mm4.2 / 4.7 / 5.2mm1.0 mm, 1.5 mm, 2.0mm, 3.0 mm, 4.0 mm,5.0 mm, 7.0 mm

6.2.9. Direct Healing Abutment

Candidate:Reference Device:
CompanyMedical Instinct Deutschland GmbHNobel Biocare USA LLCDiscussion
DeviceNameBoneTrust® Direct Healing AbutmentsHealing Cap Multi-Unit Titanium--
510(K)number--K171142--
Maximumintraoral use180 Days180 DaysIdentical
LoadNon-occlusal loadingNon-occlusal loadingIdentical
MaterialTitanium alloy TiAl4VTitanium alloy Ti6Al4V ELI(ASTM F136)Identical
Surfaceanodized surfaceanodized surfaceIdentical
ConnectionCylindrical external Hexagon or and conicaltorxConical fittingResults of dynamicfatigue testing supportthat differences ininner geometry do notraise any concerns inregard to safety andeffectiveness of theimplant - abutmentinterface
SizeHealing Cap Height: 4.75 mmHealing Cap Diameter 4.9 mmHealing Cap Height: 4.1 and 5.5 mmHealing Cap Diameter 5.0, 6.0, 6.9 mmSizes are within rangeof K171142, exceptHealing Cap Diameteris 0.1 mm smaller.This difference is dueto the specific fitting tothe abutment anddoes not raise anyconcerns in regard tosafety and effective-ness of the proposeddevices
CompatibleAbutmentsBone Trust® Direct AbutmentsNobel Biocare Multi Unit AbutmentsAdapted to fit manu-facturer's abutmentsystem

{19}------------------------------------------------

m

CompanyCandidate:Reference Device:Discussion
Medical Instinct Deutschland GmbHStraumann USA
DeviceNameBoneTrust® Healing Abutments Wide BodyHealing Abutment--
510(K)number--K130808--
Maximumintraoral use180 Days180 DaysIdentical
LoadNon-occlusal loadingNon-occlusal loadingIdentical
MaterialTitanium alloy TiAl4VTitanium alloy Ti6Al4V ELI(ASTM F136)Identical
Surfaceanodized surfaceanodized surfaceIdentical
ConnectionCylindrical external Hexagon or and conicaltorxConical fittingResults of dynamicfatigue testing supportthat differences ininner geometry do notraise any concerns inregard to safety andeffectiveness of theimplant - abutmentinterface
SizePlatform DiameterGingival Height(GH)Plattform Diameters: 3.3mm, 3.5mm,4.1mm, 4.8mm, 6.5mmGingival Heights:2.0mm, 3.5mm, 4.0mm, 5.0mm, 6.0 mmWithin range of refer-ence device
3.4 mm / 4.0 mm3.0 mm, 5.0 mm
5.0 mm3.0 mm, 5.0 mm

6.2.10. Healing Abutment Wide Body

7. Performance testing

7.1. Summary of Clinical Testing

No clinical studies were performed for the BoneTrust® Implant System

7.2. Summary of non-Clinical Testing

The following nonclinical testing data were provided or relied upon in support of the substantial equivalence determination.

7.2.1. Biocompatibility

Biocompatibility assessment has been performed according to ISO 10993 series and included testing for cytotoxicity according to ISO 10993-5.

Results support substantial equivalence of the BoneTrust® implants to legally marketed predicate devices.

{20}------------------------------------------------

7.2.2. Fatigue testing

Fatigue testing of the implant-abutment interface has been tested for representative samples in accordance with ISO 14801.

Results support substantial equivalence of the BoneTrust® implants to legally marketed predicate devices.

7.2.3. Sterilization

Validation of sterilization instructions for non-sterile devices have been conducted according to ISO 17665-1 and ISO 17665-2 for pre-vacuum steam sterilization (wrapped cycle) demonstrating a sterility assurance level (SAL) of 10-6.

Sterilization validation for device delivered sterile has been conducted according to ISO 11137-1 and 11137-2 for Beta-radiation sterilization. Shelf life testing has been conducted according to ISO 11607-1 and ASTM F1980 under consideration of accelerated and real-time ageing conditions. LAL testing was conducted according to USP 85 and the FDA Guidance "Submission and Review of Sterility information in Premarket Notification 510k Submissions for Devices Labeled as Sterile."

7.2.4. Implant Surface Analysis

Investigation of the implant surface included Energy Dispersive X-ray Spectroscopy (EDX), SEM (Scanning Electron Microscopy) and BSE (Back-Scattered-Electrons / secondary electrons analysis. Results support substantial equivalence of the BoneTrust® implants to legally marketed predicate devices.

Non-clinical Performance Data BoneTrust® Short Implants 7.2.5.

In order to verify substantial equivalence to already marketed devices. BoneTrust® short implants were subjected to the following non-clinical performance studies:

  • . Comparative Surface area analysis
  • . Comparative Bone-to-implant contact study using animal histology
  • . Comparative pull-out strength test

Results support substantial equivalence of the BoneTrust® short implants to legally marketed predicate devices.

Conclusion as to Substantial Equivalence 8.

Based on the comparison of the indications for use, the technological characteristics and the nonclinical testing it can be concluded that the BoneTrust® Implant System is substantially equivalent to the predicate devices.

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.